ATIR101 administered after T-cell-depleted haploidentical HSCT reduces NRM and improves overall survival in acute leukemia (Q89665046)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32047237 AND SRC:MED&resulttype=core&format=json

7 April 2020

title

ATIR101 administered after T-cell-depleted haploidentical HSCT reduces NRM and improves overall survival in acute leukemia (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32047237 AND SRC:MED&resulttype=core&format=json

7 April 2020

1 reference

15

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32047237 AND SRC:MED&resulttype=core&format=json

7 April 2020

4

Philippe Lewalle

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32047237 AND SRC:MED&resulttype=core&format=json

7 April 2020

1

Denis Claude Roy

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32047237 AND SRC:MED&resulttype=core&format=json

7 April 2020

author name string

Irwin Walker

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32047237 AND SRC:MED&resulttype=core&format=json

7 April 2020

Johan Maertens

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32047237 AND SRC:MED&resulttype=core&format=json

7 April 2020

Eduardo Olavarria

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32047237 AND SRC:MED&resulttype=core&format=json

7 April 2020

Dominik Selleslag

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32047237 AND SRC:MED&resulttype=core&format=json

7 April 2020

Sylvie Lachance

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32047237 AND SRC:MED&resulttype=core&format=json

7 April 2020

Marc Buyse

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32047237 AND SRC:MED&resulttype=core&format=json

7 April 2020

Kun Wang

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32047237 AND SRC:MED&resulttype=core&format=json

7 April 2020

Jeroen Rovers

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32047237 AND SRC:MED&resulttype=core&format=json

7 April 2020

Irene Santi

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32047237 AND SRC:MED&resulttype=core&format=json

7 April 2020

Halvard Bonig

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32047237 AND SRC:MED&resulttype=core&format=json

7 April 2020

Andrew Sandler

13

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32047237 AND SRC:MED&resulttype=core&format=json

7 April 2020

Jurjen Velthuis

14

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32047237 AND SRC:MED&resulttype=core&format=json

7 April 2020

publication date

11 February 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32047237 AND SRC:MED&resulttype=core&format=json

7 April 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32047237 AND SRC:MED&resulttype=core&format=json

Indications for allo- and auto-SCT for haematological diseases, solid tumours and immune disorders: current practice in Europe, 2015.

7 April 2020

cites work

1 reference

https://api.crossref.org/works/10.1038/S41375-020-0733-0

7 January 2021

Race/ethnicity affects the probability of finding an HLA-A, -B, -C and -DRB1 allele-matched unrelated donor and likelihood of subsequent transplant utilization

1 reference

https://api.crossref.org/works/10.1038/S41375-020-0733-0

7 January 2021

Is the use of unrelated donor transplantation leveling off in Europe? The 2016 European Society for Blood and Marrow Transplant activity survey report

1 reference

https://api.crossref.org/works/10.1038/S41375-020-0733-0

7 January 2021

Is a matched unrelated donor search needed for all allogeneic transplant candidates?

1 reference

https://api.crossref.org/works/10.1038/S41375-020-0733-0

7 January 2021

Haploidentical transplant with posttransplant cyclophosphamide vs matched unrelated donor transplant for acute myeloid leukemia

1 reference

https://api.crossref.org/works/10.1038/S41375-020-0733-0

7 January 2021

1 reference

https://api.crossref.org/works/10.1038/S41375-020-0733-0

7 January 2021

Unmanipulated haploidentical transplants compared with other alternative donors and matched sibling grafts

1 reference

https://api.crossref.org/works/10.1038/S41375-020-0733-0

7 January 2021

Outcomes of haploidentical vs matched sibling transplantation for acute myeloid leukemia in first complete remission

1 reference

https://api.crossref.org/works/10.1038/S41375-020-0733-0

7 January 2021

Haploidentical transplant for myelodysplastic syndrome: registry-based comparison with identical sibling transplant.

1 reference

https://api.crossref.org/works/10.1038/S41375-020-0733-0

7 January 2021

Haploidentical versus Matched-Sibling Transplant in Adults with Philadelphia-Negative High-Risk Acute Lymphoblastic Leukemia: A Biologically Phase III Randomized Study.

1 reference

https://api.crossref.org/works/10.1038/S41375-020-0733-0

7 January 2021

Comparison of outcomes following transplantation with T-replete HLA-haploidentical donors using post-transplant cyclophosphamide to matched related and unrelated donors for patients with AML and MDS aged 60 years or older

1 reference

https://api.crossref.org/works/10.1038/S41375-020-0733-0

7 January 2021

Haploidentical vs. unrelated allogeneic stem cell transplantation for acute lymphoblastic leukemia in first complete remission: on behalf of the ALWP of the EBMT

1 reference

https://api.crossref.org/works/10.1038/S41375-020-0733-0

7 January 2021

Modern approaches to HLA-haploidentical blood or marrow transplantation

1 reference

https://api.crossref.org/works/10.1038/S41375-020-0733-0

7 January 2021

A comparison between allogeneic stem cell transplantation from unmanipulated haploidentical and unrelated donors in acute leukemia.

1 reference

https://api.crossref.org/works/10.1038/S41375-020-0733-0

7 January 2021

Durable engraftment of major histocompatibility complex-incompatible cells after nonmyeloablative conditioning with fludarabine, low-dose total body irradiation, and posttransplantation cyclophosphamide

1 reference

https://api.crossref.org/works/10.1038/S41375-020-0733-0

7 January 2021

HLA-haploidentical bone marrow transplantation for hematologic malignancies using nonmyeloablative conditioning and high-dose, posttransplantation cyclophosphamide

1 reference

https://api.crossref.org/works/10.1038/S41375-020-0733-0

7 January 2021

Leukemia relapse following unmanipulated haploidentical transplantation: a risk factor analysis on behalf of the ALWP of the EBMT

1 reference

https://api.crossref.org/works/10.1038/S41375-020-0733-0

7 January 2021

A survey of fully haploidentical hematopoietic stem cell transplantation in adults with high-risk acute leukemia: a risk factor analysis of outcomes for patients in remission at transplantation

1 reference

https://api.crossref.org/works/10.1038/S41375-020-0733-0

7 January 2021

Outcome of children with acute leukemia given HLA-haploidentical HSCT after αβ T-cell and B-cell depletion

1 reference

https://api.crossref.org/works/10.1038/S41375-020-0733-0

7 January 2021

1 reference

https://api.crossref.org/works/10.1038/S41375-020-0733-0

7 January 2021

Improved immune recovery after transplantation of TCRαβ/CD19-depleted allografts from haploidentical donors in pediatric patients

1 reference

https://api.crossref.org/works/10.1038/S41375-020-0733-0

7 January 2021

Inducible caspase-9 suicide gene controls adverse effects from alloreplete T cells after haploidentical stem cell transplantation

1 reference

https://api.crossref.org/works/10.1038/S41375-020-0733-0

7 January 2021

Long-term outcome after haploidentical stem cell transplant and infusion of T cells expressing the inducible caspase 9 safety transgene

1 reference

https://api.crossref.org/works/10.1038/S41375-020-0733-0

7 January 2021

Infusion of suicide-gene-engineered donor lymphocytes after family haploidentical haemopoietic stem-cell transplantation for leukaemia (the TK007 trial): a non-randomised phase I-II study.

1 reference

https://api.crossref.org/works/10.1038/S41375-020-0733-0

7 January 2021

Selective T-cell depletion targeting CD45RA reduces viremia and enhances early T-cell recovery compared with CD3-targeted T-cell depletion

1 reference

https://api.crossref.org/works/10.1038/S41375-020-0733-0

7 January 2021

Elimination of alloreactive T cells using photodynamic therapy

1 reference

https://api.crossref.org/works/10.1038/S41375-020-0733-0

7 January 2021

P-glycoprotein targeting: a unique strategy to selectively eliminate immunoreactive T cells

1 reference

https://api.crossref.org/works/10.1038/S41375-020-0733-0

7 January 2021

Photodynamic purging of alloreactive T cells for adoptive immunotherapy after haploidentical stem cell transplantation

1 reference

https://api.crossref.org/works/10.1038/S41375-020-0733-0

7 January 2021

Eradication of multiple myeloma and breast cancer cells by TH9402-mediated photodynamic therapy: implication for clinical ex vivo purging of autologous stem cell transplants

1 reference

https://api.crossref.org/works/10.1038/S41375-020-0733-0

7 January 2021

A clinical-scale selective allodepletion approach for the treatment of HLA-mismatched and matched donor-recipient pairs using expanded T lymphocytes as antigen-presenting cells and a TH9402-based photodepletion technique

1 reference

https://api.crossref.org/works/10.1038/S41375-020-0733-0

7 January 2021

Allodepleted T-cell immunotherapy after haploidentical haematopoietic stem cell transplantation without severe acute graft-versus-host disease (GVHD) in the absence of GVHD prophylaxis

1 reference

https://api.crossref.org/works/10.1038/S41375-020-0733-0

7 January 2021

Randomized, controlled trials, observational studies, and the hierarchy of research designs

1 reference

https://api.crossref.org/works/10.1038/S41375-020-0733-0

7 January 2021

Developing improved observational methods for evaluating therapeutic effectiveness.

1 reference

https://api.crossref.org/works/10.1038/S41375-020-0733-0

7 January 2021

Composite end point of graft-versus-host disease-free, relapse-free survival after allogeneic hematopoietic cell transplantation

1 reference

https://api.crossref.org/works/10.1038/S41375-020-0733-0

7 January 2021

Validation and refinement of the Disease Risk Index for allogeneic stem cell transplantation

1 reference

https://api.crossref.org/works/10.1038/S41375-020-0733-0

7 January 2021

Prophylaxis and treatment of GVHD: EBMT-ELN working group recommendations for a standardized practice.

1 reference

https://api.crossref.org/works/10.1038/S41375-020-0733-0

7 January 2021

Toxicities of tacrolimus and cyclosporin A after allogeneic blood stem cell transplantation

1 reference

https://api.crossref.org/works/10.1038/S41375-020-0733-0

7 January 2021

1 reference

https://api.crossref.org/works/10.1038/S41375-020-0733-0

7 January 2021

Treatment of high-risk acute leukemia with T-cell-depleted stem cells from related donors with one fully mismatched HLA haplotype

1 reference

https://api.crossref.org/works/10.1038/S41375-020-0733-0

7 January 2021

Megadose of T cell-depleted bone marrow overcomes MHC barriers in sublethally irradiated mice

1 reference

https://api.crossref.org/works/10.1038/S41375-020-0733-0

7 January 2021

Clinical applications of donor lymphocyte infusion from an HLA-haploidentical donor: consensus recommendations from the Acute Leukemia Working Party of the EBMT

1 reference

https://api.crossref.org/works/10.1038/S41375-020-0733-0

7 January 2021

The European Society for Blood and Marrow Transplantation (EBMT) consensus recommendations for donor selection in haploidentical hematopoietic cell transplantation

1 reference

https://api.crossref.org/works/10.1038/S41375-020-0733-0

7 January 2021

CMV-specific immune reconstitution following allogeneic stem cell transplantation

1 reference

https://api.crossref.org/works/10.1038/S41375-020-0733-0

7 January 2021

T cells for viral infections after allogeneic hematopoietic stem cell transplant

1 reference

https://api.crossref.org/works/10.1038/S41375-020-0733-0

7 January 2021

Establishment and Operation of a Third-Party Virus-Specific T Cell Bank within an Allogeneic Stem Cell Transplant Program

1 reference

https://api.crossref.org/works/10.1038/S41375-020-0733-0

7 January 2021

Prediction of graft-versus-host disease in humans by donor gene-expression profiling

1 reference

https://api.crossref.org/works/10.1038/S41375-020-0733-0

7 January 2021

Outcomes of acute leukemia patients transplanted with naive T cell-depleted stem cell grafts

1 reference

https://api.crossref.org/works/10.1038/S41375-020-0733-0

7 January 2021

Naïve subset develops the most important alloreactive response among human CD4 T lymphocytes in human leukocyte antigen-identical related setting.

1 reference

https://api.crossref.org/works/10.1038/S41375-020-0733-0

7 January 2021

Alloreactive and leukemia-reactive T cells are preferentially derived from naive precursors in healthy donors: implications for immunotherapy with memory T cells.

1 reference

https://api.crossref.org/works/10.1038/S41375-020-0733-0

7 January 2021

A direct estimate of the human alphabeta T cell receptor diversity

1 reference

https://api.crossref.org/works/10.1038/S41375-020-0733-0

7 January 2021

The potential role of γδ T cells after allogeneic HCT for leukemia

1 reference

https://api.crossref.org/works/10.1038/S41375-020-0733-0

7 January 2021

NK Cells Mediate a Crucial Graft-versus-Leukemia Effect in Haploidentical-HSCT to Cure High-Risk Acute Leukemia

1 reference

https://api.crossref.org/works/10.1038/S41375-020-0733-0

7 January 2021

Increased risk of leukemia relapse with high-dose cyclosporine A after allogeneic marrow transplantation for acute leukemia

1 reference

12 December 2020

The significance of follow-up treatment for the hospital requirements of schizophrenic women

1 reference

12 December 2020

Effect of graft-versus-host disease prophylaxis on relapse in patients transplanted for acute myeloid leukemia

1 reference

12 December 2020

Graft versus host disease prophylaxis with low-dose cyclosporine-A reduces the risk of relapse in children with acute leukemia given HLA-identical sibling bone marrow transplantation: results of a randomized trial

1 reference

12 December 2020

Full haplotype-mismatched hematopoietic stem-cell transplantation: a phase II study in patients with acute leukemia at high risk of relapse.

1 reference

12 December 2020

Long-Term Survival and Late Deaths After Allogeneic Hematopoietic Cell Transplantation

1 reference

12 December 2020

T-cell-replete HLA-haploidentical hematopoietic transplantation for hematologic malignancies using post-transplantation cyclophosphamide results in outcomes equivalent to those of contemporaneous HLA-matched related and unrelated donor transplantati

1 reference

12 December 2020